Conceptos Categóricos

Crónicas de autores

Alex Sanjuan *

Autor invitado por SIIC

El trabajo contribuye a resolver la controversia en el tratamiento del cáncer de endometrio tipo endoemtrioide

RECURRENCIAS Y SUPERVIVENCIA EN EL TRATAMIENTO QUIRURGICO DEL CANCER DE ENDOMETRIO TIPO ENDOMETRIOIDE

Nuestros resultados sugieren que en las pacientes tratadas quirúrgicamente por un carcinoma endometrioide de endometrio la braquiterapia protegería de las recurrencias. En cambio, ni la linfadenectomía ni el tipo de intervención quirúrgica afectarían el número de recurrencias ni la supervivencia global.

*Alex Sanjuan
describe para SIIC los aspectos relevantes de su trabajo
RECURRENCE AND SURVIVAL IN SURGICALLY TREATED ENDOMETRIOID ENDOMETRIAL CANCER
Clinical & Translational Oncology,
10(8):505-511 Ago, 2008

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*H.clinic, Barcelona, España
Imprimir nota
Referencias bibliográficas
1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003.
2. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. Cancer 60:2035-41, 1987.
3. Benedet JL, Bender H, Jones H, Ngan HYS, Pecorelli S. FIGO staging classifications and clinical practices guidelines in the management of gynaecological cancers. Inter J Gynaecol Obstet 70:209-62, 2000.
4. Creutzberg CL. Lymphadenectomy in apparent early-stage endometrial carcinoma: do numbers count? J Clin Oncol 23 (16):1-3, 2005.
5. Eltabbakh GH. Analysis of survival after laparoscopy in women with endometrial carcinoma. Cancer 95:1894-901, 2002.
6. Sanjuán A, Hernández S, Pahisa J, Ayuso JR, Torné A, Martínez Román S, Lejárcegui JA, Vanrell JA. Port-site metastasis after laparoscopic surgery for endometrial carcinoma: two case reports. Gynecol Oncol 96:539-42, 2005.
7. Tozzi R, Malur S, Koehler C, Schneider A. Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12(2):130-6, 2005.
8. Burke TW. Role of radiation treatment in intermediate risk endometrial cancer. Int J Gynecol Cancer 15(2):409, 2005.
9. Obermair A, Manolitsas TP, Leng Y, Hammond IG, McCartney AJ. Total laparoscopy hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 92:789-93, 2004.
10. Boronow RC, Morrow CP, Creasman WT et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825-32, 1984.
11. Malur S, Possover M, Michels W, Schneider A. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer-a prospective randomized trial. Gynecol Oncol 80:239-44, 2001.
12. Gemignani ML, Curtin JP, Zelmanovich J, Patel DA, Venkatraman E, Barakat RR. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol Oncol 73:5-11, 1999.
13. Holub Z, Jabor A, Bartos P, Eim J, Urbanek S, Pivovarnikova R. Laparoscopic surgery for endometrial cancer: long-term results of a multicentric study. Eur J Gynaecol Oncol 23(4):305-10, 2002.
14. Holub Z. The role of laparoscopy in the surgical treatment of endometrial cancer. Clin Exp Obstet Gynecol 30(1):7-12, 2003.
15. Franchi M, Ghezzi F, Riva C, Miglierina M, Buttarelli M, Bolis P. Postoperative complications alter pelvis lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol 78:232-40, 2001.
16. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182:1506-19, 2000.
17. Creutzberg CL, Van Putten WLJ, Koper PCM, Lybeert MLM, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KAJ, Lutgens L, Van der Bergh ACM, Van de Steen-Banasik E, Beerman H, Van Lent M. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-I endometrial carcinoma: multicentre randomized trial. Lancet 355:1404-11, 2000.
18. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340-3, 1998.
19. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Alvarez Second A, Saper JT, Clarke-Pearson DL, Berchuck A. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23(16):3668-75, 2005.
20. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56:29-33, 1995.
21. Sanjuán A, Cobo T, Pahisa J, Escaramís G, Ordi J, Ayuso JR, Garcia S, Hernández S, Torné A, Martínez Román S, Lejárcegui JA, Vanrell JA. Preoperative and intraoperative assessment of myometrial invasion and histological grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer; in press, 2005.
22. Creutzberg CL. Lymphadenectomy in apparent early-stage endometrial carcinoma: do numbers count? J Clin Oncol 23(16):3653-5, 2005.
23. Straughn JM, Huh WK, Orr JW, Kelly FJ, et al. Stage IC adenocarcinoma of the endometrium: survival comparison of surgically staged patients with and without adjuvant radiation therapy. Gyncol Oncol 89:295-300, 2003.
24. Creutzberg CL, Van Putten WLJ, Koper PCM, et al. The morbidity of treatment for patients with stage-I endometrial carcinoma: results from a randomized trial. Int J Radiat Oncol Biol Phys 51:1246-55, 2001.
25. Creutzberg CL, Van Putten WLJ, Warlam-Rodenhuis CC, Van der Bergh ACM, De Winter KAJ, Koper PCM, Lybeert MLM, Slot A, Lutgens L, Stenfert Kroese MC, Beerman H, Van Lent M. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol 22:1234-41, 2004.
26. Scholten AN, Van Putten WLJ, Beerman H, Smit VTHBM, Koper PCM, Lybeert MLM, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KAJ, Lutgens L, Van Lent M, Creutzberg CL. Postoperative radiotherapy for stage-I endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Rad Oncol Biol Phys in press, 2005.
27. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a GOG study. Gynecol Oncol 92:744-751, 2004.
28. Burke TW. Role of radiation treatment in intermediate risk endometrial cancer. Int J Gynecol Cancer 15(2):409, 2005.
29. Jolly S, Vargas C, Kumar T, Weiner S, Brabbins D, Chen P, Floyd W, Martinez AA. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 97:887-92, 2005.
30. Alektiar KM, Venkatraman E, Chi DS, Barakat RR. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Rad Oncol Biol Phys 62(1):111-7, 2005.
31. Mariani A, Dowdy SC, Keeney GL, Haddock MG, Lesnick T, Podratz KC. Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol 97:820-7, 2005.
32. Creutzberg CL. GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma? Gynecol Oncol 92:740-3, 2004.


ua40317
-->